{"id":326770,"date":"2026-10-26T15:06:11","date_gmt":"2026-10-26T09:36:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=326770"},"modified":"2026-10-26T15:06:11","modified_gmt":"2026-10-26T09:36:11","slug":"sakar-healthcare-share-rises-after-q2-results-up-over-500-percent-in-5-years-will-the-rally-continue-target-sl","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sakar-healthcare-share-rises-after-q2-results-up-over-500-percent-in-5-years-will-the-rally-continue-target-sl\/","title":{"rendered":"Sakar Healthcare Share Rises After Q2 Results: Up Over 500% in 5 Years, Will the Rally Continue? Check Target and Stop Loss"},"content":{"rendered":"

Sakar Healthcare shares rose as much as 9.2% to Rs 972 on NSE on Monday, 26 Oct 2026, and traded near Rs 966.80 around 2:54 PM, up 8.65% from Friday’s close of Rs 889.80. The oncology-focused company reported Q2 FY27 net profit of Rs 11.31 crore, up about 149% year on year, on revenue of Rs 87.42 crore, up 51.9%. The share is up about 531% in five years (my calculation) but about 21% below its 52-week high.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Sakar Healthcare share is rising because Q2 FY27 profit jumped to Rs 11.31 crore from Rs 4.54 crore and the EBITDA margin widened to about 28% from about 20%, helped by a better oncology mix and operating gearing. The rebound follows a volatile results day, when the stock spiked to Rs 1,019 and then closed down 6.51% at Rs 889.80. At about 50 times trailing earnings and a daily trend that is still down, the rally has to be earned by further growth. This is educational and not a recommendation to buy or sell.<\/p>\n<\/p><\/div>\n

The Sakar Healthcare share price is up about 8.7% on Monday after a results-day swing that saw the stock open higher, touch Rs 1,019 and end lower on Friday. Whether the Sakar Healthcare share rally continues depends on whether the profit and margin gains in the Q2 numbers can be repeated, and on whether the stock can clear the resistance levels set out below.<\/p>\n

I could not retrieve an expert Sakar Healthcare share price target or stop loss for this stock, and I found no brokerage coverage with price targets, so the levels here come from indicators and price history. This article covers the day’s move, the Q2 numbers, the five-year run, valuation, shareholding, technical levels and risks. It is educational and not advice.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n